We report observations of an intrinsic fluorescence in the visible range, which develops during the aggregation of a range of polypeptides, including the disease-related human peptides amyloid-b (1-40) and (1-42), lysozyme and tau. Characteristic fluorescence properties such as the emission lifetime and spectra were determined experimentally. This intrinsic fluorescence is independent of the presence of aromatic side-chain residues within the polypeptide structure. Rather, it appears to result from electronic levels that become available when the polypeptide chain folds into a cross-b sheet scaffold similar to what has been reported to take place in crystals. We use these findings to quantify protein aggregation in vitro by fluorescence imaging in a label-free manner.
Introduction
The phenomenon by which some proteins undergo structural changes from their native states into b-sheet rich brillar aggregates is of intense current interest, both for establishing a fundamental understanding of the process of protein misfolding and to relate the association of misfolded states with neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), type II diabetes and various types of amyloidosis. 1 In addition, as a biomaterial, amyloid brils are self-assembling supramolecular polymers with considerable stability, mechanical strength and stiffness. 2 Extensive biophysical investigations have been carried out to characterize amyloid structures in increasing detail, [3] [4] [5] [6] [7] [8] but reports of spectroscopic studies that probe the electronic structure and associated photophysical properties of amyloid brils are scarce. Knowledge of the latter is, however, of critical importance for the development and quantitative application of uorescent assays to probe protein self-assembly reactions. An improved understanding of amyloid photophysics is important not only for the development, application and quantication of optical assays for disease-associated amyloid formation, but also for the rational design of amyloid brils as novel biomaterials and nanodevices.
Recently, a uorescence-like emission was reported for synthetic structures of peptides derived from elastin and crystalline proteins. [9] [10] [11] The structures studied were devoid of aromatic residues and extrinsic uorescent labels, and contain a high proportion of b-sheets. The authors speculated that the phenomenon may have its origin in electron delocalisation caused by hydrogen bonds in the b-sheet structure so that lowenergy electronic transitions become possible. The systems studied in the previous investigations are capable of forming b-sheet structures similar to those found in protein amyloids, and it was hypothesized therefore that amyloid brils may exhibit similar photophysical properties. This prompted us to investigate the photophysics of human peptides and proteins implicated in protein misfolding diseases as they aggregate to form amyloids. In this report we show conclusively that amyloid formation is concomitant with the onset of intrinsic uorescence.
In particular, we study emergent uorescence properties during aggregation of amyloid-b peptides and the amyloidogenic proteins tau and lysozyme, 12-14 all of which are from the human genome and associated with protein misfolding diseases. 15, 16 All these polypeptides acquire intrinsic uores-cence signatures in the visible range upon aggregation. We use spectrum-and time-resolved uorescence detection and imaging, and conclude that the observed uorescence is a generic property of amyloid structures featuring a characteristic lifetime for each polypeptide investigated. The time-resolved uorescence measurements exclude possible artefacts due to inelastic scattering. Intrinsic uorescence was also detected from a fragment of amyloid-b(1-42), which is devoid of aromatics, namely amyloid-b (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . 17 This result shows that the phenomenon is not mediated by the presence of aromatic side chains and hence is not consistent with a previous report that chemical modications of aromatic residues in polypeptides during amyloid formation may lead to the formation of an intrinsic chromophore like that of GFP.
18 Rather, our results lend strong support to previous suggestions that electron delocalisation via hydrogen bonds in b-sheet structure can cause the phenomenon, 9-11 and they extend the validity of this argument to disease-relevant amyloid brils with experimental evidence. The appearance of this intrinsic uorescence signal is concomitant with the growth of amyloid structures as detected by AFM and thus provides a direct handle for detecting amyloid formation using only optical techniques. This feature permits the study in vitro of amyloid self-assembly reactions without the requirement for extrinsic labelling with uorophores, and thus eliminates any risk of perturbations due to chain modications during aggregation.
Experimental section

Preparation of peptides and proteins
The lyophilised powder of synthetic Ab(1-40), Ab(1-42) and Ab(33-42) (Bachem, Merseyside, UK), referred to as Ab40, Ab42, Ab(33-42) hereaer, were prepared via sequential treatment with triuoroacetic acid (TFA) and hexauoroisopropanol (HFIP) to remove small aggregates and stored as a lyophilised lm in Eppendorf tubes at À20 C. 19 A sample was freshly thawed for each experiment. I59T human lysozyme was expressed and puried as previously described. 20 The tau construct K18 (I260C/C291A/C322A), termed K18 hereaer, was prepared as previously described.
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Conversion of soluble polypeptides into brils Lyophilised, TFA-and HFIP-treated Ab(1-40) and Ab(1-42) were dissolved in 1Â PBS buffer (pH 7.4) at 50 mM peptide concentration in Eppendorf tubes and incubated at 37 C for 7 days.
Lyophilised, TFA-and HFIP-treated Ab(33-42) was initially dissolved in 1% NH 4 OH at 2 mM and diluted with 1Â PBS buffer (pH 7.4) to 100 mM. The sample was centrifuged (12 100 g, 10 min) to remove any undissolved peptide and the soluble fraction was incubated at 37 C for 2 days. K18 (I260C/C291A/ C322A) tau (10 mM in 50 mM ammonium acetate buffer, pH 7.0) was incubated at 37 C for 24 h, quiescent, in the presence of 2.5 mM heparin (MW $ 3000, Sigma-Aldrich, Dorset, UK). I59T human lysozyme (6.8 mM in 0.1 M sodium citrate buffer, pH 5.0) was incubated at 60 C with stirring for up to 1400 min. Hen egg white lysozyme (Sigma-Aldrich, L-6876, Lot 081K1554) was dissolved in glycine-HCl buffer, pH 2.2, ltered with 0.20 mM lters (Millipore Limited, Watford, UK), and incubated at 60 C for up to 11 days. All buffers were made with Milli-Q water and were ltered with 0.20 mM lters (Millipore Limited, Watford, UK) before use. For the kinetic assays, aliquots were taken from the well-mixed sample at designated time points, ash frozen in liquid nitrogen and stored at À20 C until imaged; aliquots were freshly thawed before each experiment. To dissociate the brils, I59T lysozyme brils were obtained by centrifuging at 13 400 rpm for 10 min and extracting the lower 20% of the solution.
The extract was added to 8 M guanidinium hydrochloride and le at room temperature for 24 h.
Fluorescence lifetime imaging microscopy (FLIM)
All FLIM images were recorded on a home built confocal microscopy platform based on a confocal microscope scanning unit (Olympus FluoView 300) coupled with an Olympus IX70 inverted microscope frame (Olympus UK, Essex, UK).
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Acquisition of FLIM images was controlled using the soware SPCM (Becker & Hickl GmbH, Berlin, Germany). For every pixel in the image (the latter consisting of 256 Â 256 pixels), a histogram of photon arrival times was recorded. The image acquisition time was 500 s. It was veried that photobleaching was insignicant aer image acquisition. Photon count rates were kept below 1% of the laser repetition rate to prevent photon pile-up. An instrumental response function was recorded by imaging the reection from a cover slip. A corresponding differential interference contrast (DIC) image was also recorded for each sample for reference using the FluoView soware. Images were rst analysed using the soware SPCImage (Becker & Hickl GmbH, Berlin, Germany). For each pixel in the image, the instrumental response function was deconvoluted from the distribution of recorded photon arrival times to produce an estimate of the uorescence intensity decay curve that was then tted to a mono-exponential function. Appropriate pixel binning and intensity thresholding were applied to improve the signal-to-noise ratios (SNR) and suppress background and scattering noise. The uorescence lifetime, photon number and quality of t (c 2 ) were recorded for each pixel, producing a 256 Â 256 array of values for each parameter. These data were then exported into MATLAB (Mathworks, USA) for further quantitative analysis and data presentation.
Atomic force microscopy (AFM)
AFM images were acquired using a VEECO Dimension 3100 atomic force microscope (Bruker AXS, Cambridge, UK). The instrument was operated in tapping mode in air with a silicon tip at a resonant frequency of 300 kHz, a spring constant of 40 N m À1 , a tip radius of 10 nm (RTESP, Bruker AXS, Cambridge, UK). Images were collected at a scan rate of 1 Hz. 5 mL of each brillar sample was deposited onto freshly cleaved mica surfaces for 2 h for adsorption. The samples were rinsed with 200 mL of Milli-Q water 5 times and le to dry completely in air before imaging.
Spectral measurements
Excitation and emission spectra were measured at 25 C using a Cary Eclipse uorescence spectrophotometer (Agilent Technologies, Oxford, UK). The excitation spectra were measured with the detection wavelength xed at 470 nm. The emission spectra were measured with the excitation wavelength xed at 357 nm. For all measurements, excitation and emission slit widths were 10 nm and 20 nm respectively; the PMT voltage was 750 V; the scan speed was 120 nm min À1 .
Confocal microscopy
A commercial confocal microscope (Leica TCS SP5, Leica Microsystems GmbH, Wetzlar, Germany) was used, with a 405 nm diode laser as the excitation source and an 63Â oil immersion objective. Emission between 450 and 500 nm was recorded. Speckle noise in the uorescence images was removed by ltering using ImageJ.
Results and discussion
Intrinsic uorescence is a generic property of the amyloid state of proteins 
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Intrinsic uorescence measurements were performed on a custom-built confocal uorescence microscope capable of measuring the uorescence excitation and emission spectra, and uorescence lifetimes with photon counting sensitivity.
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In Fig. 1 we show the uorescence intensity and corresponding uorescence emission lifetime images of the amyloid states of ve peptides and proteins following excitation at 450 nm (rows 1 and 2, respectively), as well as representative uorescence intensity decay curves (row 3) obtained by timecorrelated single photon counting uorescence lifetime imaging (TCSPC-FLIM). Analysis of the time-resolved intensity shows that the number of photons emitted in each time bin could be tted by mono-exponential decays with lifetimes between 2 and 4 ns (Fig. 1) . By contrast, no detectable uores-cence signal was observed from solutions of the monomeric states of the peptides and proteins prior to aggregation. Aggregates were also examined using a commercial uores-cence microscope (Leica TCS SP5, Leica Microsystems GmbH, Wetzlar, Germany) with a 405 nm diode laser as the excitation source and a detection wavelength range between 450 and 500 nm. Intrinsic uorescence could also be detected under these conditions, as shown in Fig. 2 . To conrm the amyloid nature of the proteins studied here we imaged all samples also using atomic force microscopy (AFM) (Fig. 2) . Furthermore, the intrinsic amyloid uorescence could be bleached by continuous irradiation, as shown in ESI Fig. 1 † for I59T lysozyme and Ab(33-42) brils. When the aggregates were exposed to the denaturant guanidinium hydrochloride (at a concentration of 8 M) they dissolved completely and the sample reverted to a non-uorescent homogeneous solution (ESI Fig. 2 †) , supporting further the amyloid-specic origin of the observed phenomenon.
Intrinsic amyloid uorescence measurements permit the direct tracking of amyloid self-assembly reactions
The ability to visualize protein amyloid structures without extrinsic labelling provides opportunities for the development of in vitro kinetic aggregation assays that are not susceptible to perturbation of the aggregating protein by dyes or labels. We therefore incubated I59T lysozyme at 60 C and pH 5.0 (conditions shown previously to generate well-dened aggregation kinetics
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) and extracted aliquots of the reacting mixture at a series of time points during the aggregation reaction. Fig. 3 illustrates that the evolution of the intrinsic uorescence of I59T lysozyme can be imaged by TCSPC-FLIM throughout the time course of the aggregation process. Fluorescence intensity and lifetime were obtained from each aliquot and the results are shown in Fig. 3A (top and bottom rows respectively) . It is clear from these images that the number of uorescent aggregates increases with time. We further analysed the number of pixels containing a uorescence signal in the resulting images and the uorescence lifetimes of the aggregates. In Fig. 3B , the number of uorescent pixels in each image is shown as a function of Fig. 2 Fluorescence from amyloid structures can be detected with a standard commercial imaging system. Rows 1-3 show confocal microscopy images, corresponding phase contrast images and AFM images, respectively, of Ab40 (A), Ab42 (B), Ab(33-42) (C), K18 tau (D) and I59T lysozyme (E). Scale bars represent 10 mm for microscopy images, and 500 nm for AFM images. aggregation time, providing a robust readout of the aggregation time course of polypeptides without any requirement for external uorescent probes. Similarly, the lifetime of the intrinsic uorescence from the aggregates increased monotonically with aggregation time, primarily during the fast growth phase (Fig. 3C) . The evolution of intrinsic uorescence upon amyloid formation can also be observed from time-lapse measurements of the excitation and emission spectra of hen egg white lysozyme (HEWL) during its aggregation reaction at pH 2.2 and 60 C (ref. 27-29) using a conventional spectrouo-rometer (Fig. 4A) . The intensity of uorescence emission increased with aggregation time. Spectral analysis indicated that for this protein the excitation and emission maxima are near 355 nm and 440 nm, respectively. These values are in close agreement with Guptasarma's results on concentrated solutions of recombinant bovine g-B-crystallin and HEWL. 30 Thus, our data suggest that the uorescence observed in soluble globular proteins is amplied upon amyloid formation when extensive b-sheets are formed, supporting Guptasarma's hypothesis that hydrogen bonding gives rise to intrinsic uorescence in these systems. Fig. 4B shows that thioavin T (ThT, 6 mM) binds to the HEWL brils formed and displays its typical excitation and emission spectra with maxima at 445 nm and 486 nm respectively, conrming the presence of amyloid structure. The intrinsic uorescence in HEWL brils was dominated by the emission of ThT under these conditions.
The current study provides evidence that amyloid structures, including those of relevance to human disease, can accept energy in the form of light and emit uorescence in the visible range. Furthermore we nd that the intensity of the observed uorescence correlates with the extent of aggregation in amyloidogenic proteins. The emission signatures are Stokes-shied from the excitation wavelength, are photobleachable and exhibit lifetimes in the nanosecond range, bearing all the hallmarks of a uorescence process. Yet, to observe intrinsic uorescence there is no requirement for the presence of aromatic residues in the aggregating peptide (where aromaticity oen is associated with uorescent molecules), suggesting that uorescence originates from energy states that are specic to, and characteristic of, the molecular cross b-sheet arrangement found in all amyloid structures. The uorescence correlates with the progress of aggregation, i.e. with the level of amyloid structure, permitting potent readouts of the latter to be developed in vitro (Fig. 5) , expanding the biophysical toolset available for the study of this important form of proteins 31 without the need to attach an extrinsic label as a probe of the extent of the reaction. Conventionally, uorescent probes such as thioavin T and Congo red have been used as reporters of aggregation because their uorescence properties exhibit signicant changes upon binding to amyloid structures. Despite their widespread application, however, the use of such probes can be prone to variability. For example, a highly aggregation-prone mutant of amyloid-b (DE22-Ab(1-39), known as the Japanese mutant) had been assumed incapable of forming brils; in fact conclusions drawn were in error because of a reduced binding affinity of thioavin T to the amyloid state of this peptide variant. 32 Equally, some compounds have been mistakenly identied as aggregation inhibitors because they interact directly with thioavin T and reduce its amyloid binding capacity. 33, 34 As the in vitro assay described here requires no chemical modication or labelling, there is no risk of any perturbation of the aggregation process. It is noted that although the intrinsic uorescence does not require any binding of external probes, any potential inhibitors tested which are themselves uorescent, or are uorescence quenchers, could affect the effectiveness of this technique in certain cases.
For in vivo applications a readout based solely on intrinsic uorescence is unlikely to be quantitative or reproducible because of competing autouorescence from living cells and organisms, which reduces both the specicity and sensitivity of the assay. However, the phenomenon described here provides potential for the development of specic and sensitive in vivo probes via external uorophores covalently attached to the amyloid backbone. 23 The latter can be specically excited and act as donors in a hetero-FRET energy transfer processes to energy states associated with the amyloid structure (Fig. 5) . The degree of FRET observed correlates with the extent of aggregation and can be readily quantied via concomitant donor uo-rescence lifetime changes. In contrast to homoFRET, 35 only low labelling densities are required and the potential for steric perturbation of aggregation reactions is reduced.
The observation of uorescent emission from the amyloid states of protein raises fundamental questions about the electronic structure of the amyloid state of polypeptide molecules. In Fig. 3C we show that the lifetime of the intrinsic uorescence from the aggregate of species increases monotonically with aggregation time, notably during the fast growth phase, which suggests that the phenomenon is intrinsically linked to the molecular structural changes taking place during amyloid formation. Thus, the lifetime of the intrinsic uorescence provides extra information on the formation of amyloid structures, in addition to the quantity of insoluble aggregates as shown in Fig. 3A and B. Similar accounts of strong UV-A uo-rescence emission from b-sheet rich structures have suggested that the formation of extensive arrays of hydrogen bonds may give rise to sufficient delocalisation of the electrons associated with the formation of hydrogen bonds, which could then give rise to optically excitable energy states 9-11 (illustrated in ESI Fig. 3 †) . A detailed understanding of the electronic transitions that could give rise to the observed optical properties is, however, still required. Quantum mechanical studies on model amyloid systems have been reported, which show that hydrogen bonds in the amyloid state are cooperative and contribute to the stability of the cross-b structures. 36, 37 We envisage that the experimental evidence reported in the present study will encourage studies in the future of the excited electronic states of amyloid systems. Further spectroscopic studies on a wide range of different amyloid systems should, therefore, yield new molecular-level structural information as well as enable the process of amyloid formation to be monitored with uorescence techniques in a label-free manner.
